Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Marketmind: Rate hikes on my mind

Published 01/17/2022, 02:52 AM
Updated 01/17/2022, 02:56 AM
© Reuters. Traders work on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., January 12, 2022.  REUTERS/Brendan McDermid

A look at the day ahead from Danilo Masoni.

It's been a turbulent start of the year for world markets with the prospect of interest rate hikes in the U.S. starting to skim the froth off global equity valuations and leaving investors wondering for how long the bull run would continue.

Talk about the Federal Reserve turning off the tap on massive stimulus is here to stay but with the earnings season kicking off on Wall Street risk sentiment could find some comfort as corporates report double digit profit increases.

And for the coming week investors will be also spared hawkish speeches from Fed officials now in blackout mode before a policy meeting on Jan 26.

S&P 500 earnings are expected to have grown 23.1% in the last three months of 2021 and STOXX 600 earnings are seen up 48.5%. Yet the bar is high and management teams might find it harder to please markets accustomed to stellar corporate growth.

Shares in most big Wall Street banks fell on disappointing numbers last week, leading to two consecutive weekly losses for the U.S.'s main equity benchmark. Today it will be quieter as Wall Street is closed for Martin Luther King Day.

Meantime, European index futures pointed to slight gains at the open. In Asia, China's central bank unexpectedly cut the borrowing costs of its medium-term loans for the first time since April 2020 to cushion an economic slowdown. And Chinese stocks advanced.

Finally, Credit Suisse (SIX:CSGN) Chairman Antonio Horta-Osorio has quit following an internal probe into his personal conduct, raising questions over the embattled lender's new strategy. Its shares rose 2% ahead of the cash market open.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Key developments that should provide more direction to markets on Monday: * China's economy rebounded in 2021 from itspandemic-induced slump but the pace slowed further in Q4 off theback of weak consumption and a property downturn * GlaxoSmithKline (NYSE:GSK) rejected a 50-billion-pound offer fromUnilever for its consumer goods arm, saying it undervalued thebusiness * ECB speaker: President Christine Lagarde * Davos WEF starts * EU finance ministers meet * German foreign min Baerbock visits Ukraine * UK Rightmove (OTC:RTMVY) House prices Jan

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.